Year: 2025
Type: erratum
Abstract: In the version of this article initially published, a patient’s KRAS mutation was mistakenly documented as a PIK3CA mutation in the original data. In Table 1, the incorrect entries in the “ PIK3CA mutation present, n (%)” section— P value (0.459); Mutated: Yes (6 (54.5)), No (5 (45.5)); Wild-type: Yes (16 (69.6)), No (7 (30.4))—have been updated to P value (0.717); Mutated: Yes (5 (45.5)), No (6 (54.5)); Wild-type: Yes (13 (56.5)), No (10 (43.5)). In the “Survival after ICB in the OCCC cohort” section of main text, in the sentence now reading “Next-generation sequencing analysis of tumour biopsies identified ARID1A and PIK3CA somatic mutations or alterations in the majority of patients (73.5% and 52.9%, respectively)” 52.9% replaces “55.9%”. Additionally, there were a few mutations with mislabeled mutation types in Extended Data Fig. 1b. Extended Data Fig. 1b and accompanying source data have been updated. These errors do not affect the results or conclusions of the study. The changes have been made in the HTML and PDF versions of the article.
Source: Nature
Authors: Yibo Dai, Anne Knisely, Mitsutake Yano, Minghao Dang, Emily M. Hinchcliff, Sanghoon Lee, Annalyn Welp, Manoj Chelvanambi, Matthew Lastrapes, Heng Liu, Zhe Yuan, Chen Wang, Hao Nie, Stephanie Jean, Luis J. Montaner, Jiakai Hou, Ami Patel, Shrina Patel, Bryan Fellman, Ying Yuan, Baohua Sun, Renganayaki Krishna Pandurengan, Edwin Roger Parra Cuentas, Joseph Celestino, Yan Liu, Jinsong Liu, R. Tyler Hillman, Shannon N. Westin, Anil K. Sood, Pamela T. Soliman, Aaron Shafer, Larissa A. Meyer, David M. Gershenson, David Vining, Dhakshinamoorthy Ganeshan, Karen Lu, Jennifer A. Wargo, Weiyi Peng, Rugang Zhang, Linghua Wang, Amir A. Jazaeri
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $12,690
Funder: National Cancer Institute
OpenAlex ID: W4414014751